Skip to main content
Caplight Logo









Allegro Ophthalmics

Allegro Ophthalmics

Private
San Juan Capistrano, CaliforniaHealthcare & Life Scienceshttps://www.allegroeye.com/

Last Round

VC Round

Jul 24, 2017

Total Funding Raised

$22.65M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Allegro Ophthalmics is a biopharmaceutical company that develops novel therapies for ocular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

dry AMDrisuteganibmitochondrial stabilizersophthalmic drugsage-related macular degenerationAMDdry eye diseaseDEDclinical stage pharmabiotechvision loss reversalpharma licensingintravitreal injectionvitreoretinal diseaseoxidative stress reductionophthalmology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allegro Ophthalmics Comparables

Compare Allegro Ophthalmics with similar companies based on industry and business-model similarity.

Allegro Ophthalmics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Morningside
84%
Drusolv Therapeutics
78%
AsclepiX Therapeutics
78%

Allegro Ophthalmics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 24, 2017
GrantFeb 3, 2015
Series BJan 13, 2015

Key People

Founding team and executive leadership

Vicken Karageozian

Chief Executive Officer And President

Executive Team

Allegro Ophthalmics Investors

Notable investors and investment history

Allegro Ophthalmics investors
InvestorRounds
Helmsley Charitable TrustGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 30% MoM.

  • Jan 8, 2026

    Monthly visitors grew 340% MoM, reaching 1.3K.

Allegro Ophthalmics Filings

Explore SEC and related filing metadata, where available.

Allegro Ophthalmics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Allegro Ophthalmics's valuation, stock price, and market status.

Is Allegro Ophthalmics a public or private company?

Allegro Ophthalmics is a private company.

What is the current stock price of Allegro Ophthalmics?

Allegro Ophthalmics is a private company with no public stock price. No recent secondary market data is available.

How much is Allegro Ophthalmics worth (valuation)?

Valuation information for Allegro Ophthalmics is not publicly available.

Can I buy Allegro Ophthalmics stock?

Allegro Ophthalmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Allegro Ophthalmics's last funding round?

Allegro Ophthalmics's most recent funding round was VC Round on July 24, 2017.

Who are the main investors in Allegro Ophthalmics?

Key investors in Allegro Ophthalmics include Helmsley Charitable Trust.

Will Allegro Ophthalmics IPO soon?

No public IPO plans have been announced for Allegro Ophthalmics.

How can I track Allegro Ophthalmics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Allegro Ophthalmics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Juan Capistrano, California
Employee Range3
Year Founded2011
Last FundingJul 24, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?